Stockscreener 앱 받기
429.33
0.77%
-3.35
시간 외 거래:
429.33
전일 마감가:
$432.68
열려 있는:
$430.15
하루 거래량:
1.16M
Relative Volume:
0.78
시가총액:
$97.95B
수익:
$176.81B
순이익/손실:
$5.98B
주가수익비율:
16.76
EPS:
25.61
순현금흐름:
$4.55B
1주 성능:
-0.28%
1개월 성능:
+8.18%
6개월 성능:
-15.01%
1년 성능:
-14.00%
1일 변동 폭
$426.31
$432.68
1주일 범위
$424.78
$438.57
52주 변동 폭
$362.21
$567.26
엘리번스 헬스 Stock (ELV) Company Profile
명칭
Elevance Health Inc
전화
(800) 331-1476
주소
220 VIRGINIA AVENUE, INDIANAPOLIS
ELV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
429.33 | 97.95B | 176.81B | 5.98B | 4.55B | 25.61 |
|
UNH
Unitedhealth Group Inc
|
523.20 | 483.13B | 400.28B | 14.41B | 20.71B | 15.50 |
|
CI
Cigna Group
|
331.92 | 89.74B | 244.38B | 3.43B | 8.96B | 12.24 |
|
CVS
Cvs Health Corp
|
68.07 | 85.71B | 372.81B | 4.61B | 6.33B | 3.66 |
|
HUM
Humana Inc
|
265.80 | 31.95B | 117.76B | 1.21B | 2.39B | 9.95 |
엘리번스 헬스 Stock (ELV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-17 | 업그레이드 | Argus | Hold → Buy |
| 2025-01-22 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | 다운그레이드 | Argus | Buy → Hold |
| 2024-07-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-06-24 | 개시 | Morgan Stanley | Overweight |
| 2024-05-30 | 개시 | Robert W. Baird | Outperform |
| 2024-03-06 | 개시 | Barclays | Overweight |
| 2023-07-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-03-28 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-22 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
모두보기
엘리번스 헬스 주식(ELV)의 최신 뉴스
Anthem — Latest Stories - Pain News Network
Q4 Rundown: Elevance Health (NYSE:ELV) Vs Other Health Insurance Providers Stocks - Barchart.com
Elevance Health, Inc. (NYSE:ELV) Shares Acquired by Wellington Management Group LLP - MarketBeat
Elevance Health Announces Key Q1 2025 Earnings Date: What Investors Should Mark on Their Calendar - Stock Titan
Here’s Why Elevance Health (ELV) Declined in Q4 - Yahoo Finance
Elevance Health, Inc. (NYSE:ELV) Shares Bought by CIBC Private Wealth Group LLC - MarketBeat
Artisan Partners Limited Partnership Boosts Stake in Elevance Health, Inc. (NYSE:ELV) - MarketBeat
Insiders At Elevance Health Sold US$12m In Stock, Alluding To Potential Weakness - Yahoo Finance
High Ground Investment Management LLP Has $77.10 Million Position in Elevance Health, Inc. (NYSE:ELV) - MarketBeat
Elevance Health, Inc. (NYSE:ELV) Shares Sold by Corebridge Financial Inc. - MarketBeat
Form DEF 14A Elevance Health, Inc. For: May 14 - StreetInsider
What Gives Elevance Health (ELV) an Attractive Opportunity in The Large Cap Space? - MSN
Bernstein raises Elevance stock target to $585 on EPS growth outlook - Investing.com India
Positive Outlook for Elevance Health: Buy Rating Driven by Recovery in Government-Managed Care Margins and Low Valuation Levels - TipRanks
Is Elevance Health, Inc.'s (NYSE:ELV) Latest Stock Performance A Reflection Of Its Financial Health? - simplywall.st
Bernstein Adjusts Price Target on Elevance Health to $585 From $511, Keeps Outperform Rating - MarketScreener
Here's How Much $100 Invested In Elevance Health 15 Years Ago Would Be Worth Today - Benzinga
Elevance Fails To Pay Wages At Termination, Worker Says - Law360
Healthcare Disruptors: AI, Telehealth and Cost Savings - Value The Markets
Elevance Enjoys Local Market Leadership in Medical Insurance - Morningstar
Elevance Health (ELV): Company Profile, Stock Price, News, Rankings - Fortune
Is Elevance Health, Inc. (NYSE:ELV) Potentially Undervalued? - Yahoo Finance
Is Elevance Health, Inc. (ELV)The Best Healthcare Dividend Stock to Invest in? - Insider Monkey
How Do Investors Really Feel About Elevance Health? - Benzinga
Is UnitedHealth Stock Still a Buy Despite Its Premium Price Tag? - TradingView
Elevance Reaches $3.3M Deal to Settle Lawsuit Over Denied Spinal Surgery Coverage - USA Herald
Elevance Inks $3.3M Deal To End Surgery Claim Denial Suit - Law360
Elevance Settles Joint Fusion Surgery Lawsuit for $2.5 Million - Bloomberg Law
Elevance Trades at a Bargain: Is it a Good Time to Buy ELV Stock? - TradingView
Argus Research Upgrades Elevance Health to Buy, $450 Price Target -March 17, 2025 at 07:58 am EDT - Marketscreener.com
Investing in Elevance Health (NYSE:ELV) five years ago would have delivered you a 134% gain - Yahoo Finance
Elevance Health’s Whole Health Index Demonstrates Opportunity to Improve Health - Business Wire
Elevance Health Foundation Exceeds $90 Million Goal to Advance Health Equity and Strengthen Communities - Business Wire
Elevance Health (NYSE:ELV) Rating Lowered to “Hold” at StockNews.com - Defense World
Trade Alert: Executive VP & President of Commercial Health Benefits Of Elevance Health Charles Kendrick Has Sold Stock - Simply Wall St
Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio (NYSE:ELV) - Seeking Alpha
Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 15 Years - Benzinga
Elevance Health, Inc. (NYSE:ELV): Waning Industry Headwinds to Boost Performance - MSN
Strength Seen in Elevance Health (ELV): Can Its 3.1% Jump Turn into More Strength? - Nasdaq
Is Elevance Health, Inc.'s (NYSE:ELV) Stock's Recent Performance A Reflection Of Its Financial Health? - Yahoo
Augusta Health, Anthem Blue Cross and Blue Shield Announce Multi-Year Contract - Augusta Health
Is Elevance Health, Inc. (ELV) the Top Health Insurance Stock to Buy Now? - Insider Monkey
Elevance Health stock gains on CFO comments (ELV:NYSE) - Seeking Alpha
Elevance Health gains after CFO comments at investor event - MSN
Elevance Health (NYSE:ELV) stock performs better than its underlying earnings growth over last five years - Simply Wall St
Rep. Jefferson Shreve Purchases Shares of Elevance Health, Inc. (NYSE:ELV) - Defense World
Elevance Health confirms 2025 earnings forecast By Investing.com - Investing.com South Africa
Elevance Health Expects FY Adjusted Earnings Of $34.15-$34.85 Per Share -March 10, 2025 at 05:40 pm EDT - Marketscreener.com
Elevance Health confirms 2025 earnings forecast - Investing.com
Elevance Health Reaffirms 2025 Earnings Guidance to Investors - TipRanks
Elevance Health, Inc. (NYSE:ELV) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
엘리번스 헬스 (ELV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.28%
자본화:
|
볼륨(24시간):